Pfizer (PFE) Reports Top-Line Results of ABRYSVO for RSV in Immunocompromised Adults
Go back to Pfizer (PFE) Reports Top-Line Results of ABRYSVO for RSV in Immunocompromised Adults| Pfizer Inc. (NYSE: PFE) | Delayed: 27.63 -0.03 (0.11%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $27.66 | 52 Week High | $37.39 | |||
| Open | $27.65 | 52 Week Low | $28.25 | |||
| Day High | $27.79 | P/E | 16.75 | |||
| Day Low | $27.53 | EPS | $1.65 | |||
| Volume | 4,152,425 | |||||

